Beijing, China

Jianmin Fu

USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 11.0

ph-index = 3

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: Jianmin Fu: Innovator in Oncological Therapeutics

Introduction

Jianmin Fu is a distinguished inventor based in Beijing, China, known for his significant contributions to the field of oncology through innovative pharmaceutical compounds. With an impressive portfolio of 23 patents, Fu has dedicated his career to developing cutting-edge therapies aimed at combatting various oncologic diseases.

Latest Patents

Among his latest innovations, Jianmin Fu has created two notable patents:

1. **Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy** - This patent outlines compounds of Formula (I), (II), and (III) along with their pharmaceutically acceptable salts. These compounds are crucial for the development of pharmaceutical compositions aimed at treating oncologic diseases.

2. **Purine inhibitors of human phosphatidylinositol 3-kinase delta** - This invention provides compounds of formula I which function as PI3K-delta inhibitors. These compounds are beneficial for treating PI3K-delta-mediated diseases, including inflammation, asthma, chronic obstructive pulmonary disease (COPD), and cancer.

Career Highlights

Jianmin Fu has held significant roles at renowned companies including Merck Sharp & Dohme Corporation and MSD R&D (China) Co., Ltd. His work in these prestigious organizations has significantly advanced the field of pharmaceutical research and development.

Collaborations

Throughout his career, Jianmin has collaborated with industry peers such as Shimin Xu and Jason David Katz, demonstrating his commitment to teamwork and innovative research.

Conclusion

Jianmin Fu's dedication to developing novel therapeutic compounds underscores his status as a leading inventor in the realm of anti-cancer treatments. With a robust patent portfolio and a solid career foundation in reputable organizations, Fu’s contributions are paving the way for advancements in oncology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…